Lina Freage-Kahn
Evaluator · DISC type csdAs Co-Founder and Chief Scientific Officer of Frezent Biological Solutions, Lina Freage-Kahn leverages her expertise in antibody discovery, immunotherapeutics, and biomolecular design. A PhD graduate from The Hebrew University of Jerusalem, she focuses on translating scientific research into real-world applications and biotech strategy.
She developed a novel immunotherapy assay using engineered DNA aptamers to activate T-cells and NK cells, which established a new research branch during her postdoctoral fellowship.
Read the full overview →How Lina shows up
They focus on the results, but can still be quite procedural and analytical about how to get there They are not very likely to become strong advocates of your product or service They have a unique set of diverse traits where they are decisive and methodical but can sometimes be extra cautious and skeptical
Topics Lina cares about
Work history
Media appearances
DISC profile (public)
Calculativeness (C)
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.